Prices delayed by at least 15 minutes | Print
Bioventix PLC (BVXP)
ORD 5POpen
4450p
Previous close
4450p
Trade high
4499p
Volume
16,374
Year high
5,100.00p
Year low
3,402.00p
Dividend yield
3.42%
Market capitalisation
£232.27 mn
P/E ratio
27.24
ISIN
GB00B4QVDF07
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Dividends
Previous | Latest | |
---|---|---|
Record date | 10/11/2023 | 12/04/2024 |
Ex-dividend date | 09/11/2023 | 11/04/2024 |
Payment date | 24/11/2023 | 26/04/2024 |
Amount | 90.00p | 68.00p |
Company profile
Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others.
News
Recent trades
Date | Time | Price | Quantity | Value (£) |
---|---|---|---|---|
28/03/2024 | 02:39:33 | 4420 | 6,000 | 265,200.00 |
28/03/2024 | 04:27:37 | 4406 | 453 | 19,959.18 |
28/03/2024 | 04:27:18 | 4400 | 455 | 20,020.00 |
28/03/2024 | 04:25:08 | 4431 | 25 | 1,107.75 |
28/03/2024 | 04:24:38 | 4499 | 22 | 989.78 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.